Co-Authors
This is a "connection" page, showing publications co-authored by NIZAR M TANNIR and RIVKAH COLEN.
Connection Strength
0.081
-
Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 03; 8(1).
Score: 0.045
-
Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors. J Clin Oncol. 2016 10 10; 34(29):3562-3569.
Score: 0.036